Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H7N9 Influenza Vaccine”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Early research (Phase 1)Study completedNCT01560793
What this trial is testing

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Who this might be right for
Influenza
VaxInnate Corporation 224
Early research (Phase 1)Study completedNCT00984945
What this trial is testing

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 48
Early research (Phase 1)Study completedNCT01236040
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 521
Early research (Phase 1)Study completedNCT00489931
What this trial is testing

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Early research (Phase 1)Study completedNCT01511419
What this trial is testing

Safety Trial of Live Attenuated Influenza (H7N3) Vaccine

Who this might be right for
InfluenzaAvian Influenza
PATH 40
Large-scale testing (Phase 3)Study completedNCT00848029
What this trial is testing

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Who this might be right for
Pre-pandemic Influenza Vaccine
Novartis Vaccines 240
Large-scale testing (Phase 3)Study completedNCT01911754
What this trial is testing

Japanese Pediatric H5N1 Vaccine Study

Who this might be right for
Influenza
Alachua Government Services, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00349141
What this trial is testing

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 270
Early research (Phase 1)Study completedNCT01250795
What this trial is testing

Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults

Who this might be right for
Healthy
Fraunhofer, Center for Molecular Biotechnology 100
Testing effectiveness (Phase 2)WithdrawnNCT01045564
What this trial is testing

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Who this might be right for
Influenza
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00895544
What this trial is testing

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

Who this might be right for
InfluenzaAvian Influenza
Alachua Government Services, Inc. 231
Testing effectiveness (Phase 2)Study completedNCT02436928
What this trial is testing

Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

Who this might be right for
H7N9 Influenza Vaccine
Medigen Vaccine Biologics Corp. 200
Testing effectiveness (Phase 2)Study completedNCT01052402
What this trial is testing

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Who this might be right for
Influenza, Avian
Alachua Government Services, Inc. 684
Large-scale testing (Phase 3)Study completedNCT02839330
What this trial is testing

Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Who this might be right for
Avian Influenza
Seqirus 3,196
Early research (Phase 1)Study completedNCT00408109
What this trial is testing

Safety Study of Avian Flu Vaccine

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableWithdrawnNCT00640211
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

Who this might be right for
Pandemic Influenza
Kirby Institute
Next Page